keyword
https://read.qxmd.com/read/37060460/risk-factors-for-acute-kidney-injury-after-high-dose-methotrexate-therapy-a-single-center-study-and-narrative-review
#1
JOURNAL ARTICLE
Chun-An Liang, Yi-Chia Su, Shyh-Jer Lin, Tsung-Hsien Tsai
PURPOSE: To assess the risk factors associated with high-dose methotrexate (HDMTX) (≥ 1 g/m2 ) treatment-induced acute kidney injury (AKI). METHODS: Patients who received HDMTX from July 2014 to August 2019 in one medical center were enrolled. The patients' demographic, laboratory, and medication data were collected and compared between groups with or without AKI. Risk factors of HDMTX-induced AKI were explored using univariate and multivariate logistic regression analyses...
April 15, 2023: European Journal of Clinical Pharmacology
https://read.qxmd.com/read/34534549/antitumoral-activity-of-liraglutide-a-new-dnmt-inhibitor-in-breast-cancer-cells-in-vitro-and-in-vivo
#2
JOURNAL ARTICLE
Andressa Chequin, Luiz E Costa, Felipe F de Campos, Angie D B Moncada, Lucas T F de Lima, Lucas R Sledz, Guilherme F Picheth, Eliana R Adami, Alexandra Acco, Marcos B Gonçalves, Graciele C M Manica, Gláucio Valdameri, Lucia de Noronha, José E Q Telles, Elisa H F Jandrey, Erico T Costa, Fabricio F Costa, Emanuel M de Souza, Edneia A S Ramos, Giseli Klassen
Breast cancer (BC) is the most frequently diagnosed female cancer and second leading cause of death. Despite the discovery of many antineoplastic drugs for BC, the current therapy is not totally efficient. In this study, we investigated the potential of repurposing the well-known diabetes type II drug liraglutide to modulate epigenetic modifications in BC cells lines in vitro and in vivo via Ehrlich mice tumors models. The in vitro results revealed a significant reduction on cell viability, migration, DNMT activity and displayed lower levels of global DNA methylation in BC cell lines after liraglutide treatment...
September 14, 2021: Chemico-biological Interactions
https://read.qxmd.com/read/31462834/mixed-etiology-leg-ulcers-in-a-patient-on-long-term-glucocorticoid-therapy
#3
Piotr Sławiński, Marcin Radkowski, Andrzej Lewandowicz, Tomasz Targowski
Chronic leg ulceration is a frequent condition in elderly patients. Chronic wounds that are nonresponsive to 3-month therapy affect approximately 6.5 million people in the United States with a prevalence of 1% and costs estimated at 25 billion dollars per year. Although the main causes are venous insufficiency, lower extremity arterial disease and diabetes, in many cases the etiology is multi-factorial. Approximately 20-23% of non-healing wounds that are refractory to vascular intervention have other etiologies including vasculitis, rheumatoid arthritis and Sjögren syndrome...
2019: Reumatologia
https://read.qxmd.com/read/25689811/no-association-between-tnf-inhibitor-and-methotrexate-therapy-versus-methotrexate-in-changes-in-hemoglobin-a1c-and-fasting-glucose-among-psoriasis-psoriatic-arthritis-and-rheumatoid-arthritis-patients
#4
COMPARATIVE STUDY
Jashin J Wu, Christopher G Rowan, Judith D Bebchuk, Mary S Anthony
BACKGROUND: The use of tumor necrosis factor inhibitors (TNFi) has been associated with a reduced incidence of type 2 diabetes mellitus. OBJECTIVE: To compare changes in hemoglobin A1C and fasting glucose for patients exposed to TNFi. METHODS: In this retrospective cohort study, patients with at least 3 recorded diagnosis codes for psoriasis, psoriatic arthritis, or rheumatoid arthritis between January 1, 2004 and July 31, 2011. Patients were Kaiser Permanente Southern California members for at least 1 year prior to the index date...
February 2015: Journal of Drugs in Dermatology: JDD
https://read.qxmd.com/read/24845391/systemic-inflammation-and-cardiovascular-risk-factors-predict-rapid-progression-of-atherosclerosis-in-rheumatoid-arthritis
#5
JOURNAL ARTICLE
Inmaculada del Rincón, Joseph F Polak, Daniel H O'Leary, Daniel F Battafarano, John M Erikson, Jose F Restrepo, Emily Molina, Agustín Escalante
OBJECTIVE: To estimate atherosclerosis progression and identify influencing factors in rheumatoid arthritis (RA). METHODS: We used carotid ultrasound to measure intima-media thickness (IMT) in RA patients, and ascertained cardiovascular (CV) risk factors, inflammation markers and medications. A second ultrasound was performed approximately 3 years later. We calculated the progression rate by subtracting the baseline from the follow-up IMT, divided by the time between the two scans...
June 2015: Annals of the Rheumatic Diseases
https://read.qxmd.com/read/23074532/ultraviolet-phototherapy-management-of-moderate-to-severe-plaque-psoriasis-an-evidence-based-analysis
#6
JOURNAL ARTICLE
(no author information available yet)
OBJECTIVE: The purpose of this evidence based analysis was to determine the effectiveness and safety of ultraviolet phototherapy for moderate-to-severe plaque psoriasis. RESEARCH QUESTIONS: The specific research questions for the evidence review were as follows: What is the safety of ultraviolet phototherapy for moderate-to-severe plaque psoriasis?What is the effectiveness of ultraviolet phototherapy for moderate-to-severe plaque psoriasis? CLINICAL NEED: TARGET POPULATION AND CONDITION Psoriasis is a common chronic, systemic inflammatory disease affecting the skin, nails and occasionally the joints and has a lifelong waning and waxing course...
2009: Ontario Health Technology Assessment Series
https://read.qxmd.com/read/22642213/meal-feeding-rodents-and-toxicology-research
#7
JOURNAL ARTICLE
Gale B Carey, Lisa C Merrill
Most laboratory rodents used for toxicology studies are fed ad libitum, with unlimited access to food. As a result, ad libitum-fed rodents tend to overeat. Research demonstrates that ad libitum-fed rodents are physiologically and metabolically different from rodents fed controlled amounts of food at scheduled times (meal-fed). Ad libitum-fed rodents can develop hypertriglyceridemia, hypercholesterolemia, diet-induced obesity, nephropathy, cardiomyopathy, and pituitary, pancreatic, adrenal, and thyroid tumors, conditions likely to affect the results of toxicology research studies...
August 20, 2012: Chemical Research in Toxicology
https://read.qxmd.com/read/22356630/the-concept-of-psoriasis-as-a-systemic-inflammation-implications-for-disease-management
#8
REVIEW
K Reich
Psoriasis is a systemic, immune-mediated disorder, characterized by inflammatory skin and joint manifestations. A range of co-morbidities is associated with psoriasis, including metabolic diseases, such as diabetes, and psychological disorders. Although the systemic nature of psoriasis often remains unrecognized, the inflammatory processes involved may be associated with the development of co-morbidities, which, themselves, have a significant impact on the patient's health and quality of life. The relative risks of myocardial infarction (MI) and stroke are increased in patients with psoriasis compared with the general population...
March 2012: Journal of the European Academy of Dermatology and Venereology: JEADV
https://read.qxmd.com/read/21777216/the-effect-of-systemic-psoriasis-therapies-on-the-incidence-of-myocardial-infarction-a-cohort-study
#9
COMPARATIVE STUDY
K Abuabara, H Lee, A B Kimball
BACKGROUND: Psoriasis confers an independent risk of cardiovascular disease that is likely to be related to systemic inflammation. Anti-inflammatory treatment could theoretically reduce the risk of cardiovascular disease, and initial data suggest that treatment may reduce the incidence of cardiovascular risk factors. OBJECTIVES: To determine the impact of anti-inflammatory therapy on the risk of acute myocardial infarction (MI) in patients with moderate-to-severe psoriasis...
November 2011: British Journal of Dermatology
https://read.qxmd.com/read/21251450/metabolic-comorbidities-and-psoriasis
#10
REVIEW
Paolo Gisondi, Anna Ferrazzi, Giampiero Girolomoni
Psoriasis is a chronic inflammatory, immune-mediated skin disease, which affects 2%-3% of the population worldwide. Chronic plaque psoriasis is frequently associated with metabolic diseases including diabetes, obesity, dyslipidemia, metabolic syndrome and nonalcoholic fatty liver disease. Although the causal relationship between metabolic comorbidities and psoriasis has not yet been completely proven, it appears that shared genetic links, common environmental factors and/or common inflammatory pathways may underlie the development of psoriasis and comorbidities...
2010: Acta Dermatovenerologica Croatica: ADC
https://read.qxmd.com/read/19607680/methotrexate-therapy-associates-with-reduced-prevalence-of-the-metabolic-syndrome-in-rheumatoid-arthritis-patients-over-the-age-of-60-more-than-just-an-anti-inflammatory-effect-a-cross-sectional-study
#11
JOURNAL ARTICLE
Tracey E Toms, Vasileios F Panoulas, Holly John, Karen M J Douglas, George D Kitas
INTRODUCTION: The metabolic syndrome (MetS) may contribute to the excess cardiovascular burden observed in rheumatoid arthritis (RA). The prevalence and associations of the MetS in RA remain uncertain: systemic inflammation and anti-rheumatic therapy may contribute. Methotrexate (MTX) use has recently been linked to a reduced presence of MetS, via an assumed generic anti-inflammatory mechanism. We aimed to: assess the prevalence of the MetS in RA; identify factors that associate with its presence; and assess their interaction with the potential influence of MTX...
2009: Arthritis Research & Therapy
https://read.qxmd.com/read/18997139/multiple-toxic-effects-of-low-dose-methotrexate-in-a-patient-treated-for-psoriasis
#12
JOURNAL ARTICLE
P Brandon Bookstaver, Leann Norris, Celeste Rudisill, Tammy DeWitt, Shahid Aziz, James Fant
PURPOSE: A case of toxicity encountered with low-dose methotrexate therapy is discussed. SUMMARY: A 59-year-old African American woman receiving long-term therapy for psoriasis came to the hospital with painful ulcers, difficulty swallowing, cutaneous lesions, and acute renal failure. Her medical history included type 2 diabetes mellitus, hypertension, coronary artery disease, morbid obesity, and psoriasis. On admission, the patient looked ill and had a low-grade fever; maculopapular skin lesions; and bullae and vesicles in her mouth and on her hands, legs, groin, and buttocks...
November 15, 2008: American Journal of Health-system Pharmacy: AJHP
https://read.qxmd.com/read/18612759/clinical-and-radiological-features-of-brain-neurotoxicity-caused-by-antitumor-and-immunosuppressant-treatments
#13
JOURNAL ARTICLE
Alessandra Erbetta, Andrea Salmaggi, Angelo Sghirlanzoni, Antonio Silvani, Paolo Potepan, Andrea Botturi, Elisa Ciceri, Maria Grazia Bruzzone
Antitumor and immunosuppressant treatment-related neurotoxicity can determine nonspecific clinical syndromes. Exclusion of other possible causes, among which tumor progression, appearance of paraneoplastic disease, renal or hepatic failure, diabetes or hypertension, is relevant. We report clinical and neuroradiological features in five patients with neurotoxic syndromes due to chemotherapy/radiotherapy or immunosuppression in the context of neoplastic disease/organ transplantation. Acute neurological syndrome developed in three patients after methotrexate (MTX), cyclosporine A, and L-asparaginase therapy, respectively...
June 2008: Neurological Sciences
https://read.qxmd.com/read/18194488/immunotherapeutic-agents-in-type-1-diabetes-a-systematic-review-and-meta-analysis-of-randomized-trials
#14
JOURNAL ARTICLE
Gunjan Y Gandhi, M Hassan Murad, David N Flynn, Mohamed B Elamin, Patricia J Erwin, Victor M Montori, Yogish C Kudva
OBJECTIVE: Although recent trial results of anti-CD3 therapy are promising, there have been conflicting results of various immunotherapeutic agents used in patients with type 1 diabetes. We conducted a systematic review and meta-analysis to determine the efficacy of nonantigen-based immunotherapeutic approaches for preservation of beta-cell function in patients with type 1 diabetes. METHODS: We searched MEDLINE, EMBASE, Cochrane CENTRAL, reference lists, and content expert files up to September 2006...
August 2008: Clinical Endocrinology
https://read.qxmd.com/read/17021761/the-importance-of-disease-associations-and-concomitant-therapy-for-the-long-term-management-of-psoriasis-patients
#15
REVIEW
Ulrich Mrowietz, James T Elder, Jonathan Barker
It is well established that several inflammatory-type conditions, such as arthritis, diabetes, cardiovascular disease, and irritable bowel disease exist comorbidly and at an increased incidence in patients with psoriasis. Psoriasis and other associated diseases are thought to share common inflammatory pathways. Conditions such as these, with similar pathogenic mechanisms involving cytokine dysregulation, are referred to as immune-mediated inflammatory diseases (IMIDs). Considerable evidence for the genetic basis of comorbidities in psoriasis exists...
December 2006: Archives of Dermatological Research
https://read.qxmd.com/read/9818800/herbal-medicinals-selected-clinical-considerations-focusing-on-known-or-potential-drug-herb-interactions
#16
REVIEW
L G Miller
Herbal medicinals are being used by an increasing number of patients who typically do not advise their clinicians of concomitant use. Known or potential drug-herb interactions exist and should be screened for. If used beyond 8 weeks, Echinacea could cause hepatotoxicity and therefore should not be used with other known hepatoxic drugs, such as anabolic steroids, amiodarone, methotrexate, and ketoconazole. However, Echinacea lacks the 1,2 saturated necrine ring associated with hepatoxicity of pyrrolizidine alkaloids...
November 9, 1998: Archives of Internal Medicine
https://read.qxmd.com/read/7608569/vascular-cell-adhesion-molecule-ig-fusion-protein-selectively-targets-activated-alpha-4-integrin-receptors-in-vivo-inhibition-of-autoimmune-diabetes-in-an-adoptive-transfer-model-in-nonobese-diabetic-mice
#17
JOURNAL ARTICLE
A Jakubowski, B N Ehrenfels, R B Pepinsky, L C Burkly
The alpha 4 beta 1-integrin (CD49d, CD29) constitutively expressed on leukocytes regulates cell migration to inflammatory sites, cell activation, and development through its interactions with two alternate ligands, vascular cell adhesion molecule-1 (VCAM-1; CD106) expressed on cytokine-activated endothelium, dendritic and stromal cells, and the extracellular matrix protein fibronectin. Another alpha 4-integrin receptor, alpha 4 beta 7, expressed on leukocytes also binds VCAM-1 and fibronectin (FN), and controls homing to mucosal tissues through its interactions with mucosal vascular addressin MAdCAM-1...
July 15, 1995: Journal of Immunology
https://read.qxmd.com/read/4716740/psoriasis-liver-methotrexate-interactions
#18
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
July 1973: Archives of Dermatology
https://read.qxmd.com/read/2236338/current-issues-in-nsaid-therapy
#19
REVIEW
L G Miller, J G Prichard
More than a dozen NSAIDs are commercially available in the United States. Diclofenac may not be as effective for dysmenorrhea. Although most are equally efficacious, indomethacin is the preferred agent for hemicrania continua and chronic paroxysmal hemicrania. Although all NSAIDs should theoretically be beneficial in gout, the greatest experience is with indomethacin. Sulindac may be the preferred agent for diabetic neuropathy. Fenoprofen appears to be the most offensive NSAID in terms of nephrotoxicity. NSAIDs may antagonize antihypertensive therapy, although this effect may not persist beyond 1 month...
September 1990: Primary Care
https://read.qxmd.com/read/1725722/angiogenesis-and-its-inhibition-potential-new-therapies-in-oncology-and-non-neoplastic-diseases
#20
REVIEW
D C Billington
To summarise the key points: The ability to mount an angiogenic response is probably present in all tissues, and stimulation of endothelial cells by any one of a wide variety of factors initiates a cascade of events leading to angiogenesis. In most tissues the overall lack of angiogenesis in normal situations probably results from the interaction of a complex series of multifactorial systems, each of which maintained in a state of balance between stimulation and inhibition. An imbalance in any one of these systems, for example by an increase in the concentration of a growth factor, may lead to angiogenesis...
November 1991: Drug Design and Discovery
keyword
keyword
106555
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.